Monday, November 20, 2017

Imee Marcos dares Callamard to try shabu for a week: Tingnan natin kung walang epek!

May 9, 2017 @ 13:20

Ilocos Norte governor Imee Marcos has dared United Nations special rapporteur on extrajudicial executions Agnes Callamard to try shabu for a week to prove her claim it does not cause brain damage.

Marcos issued the challenge to Callamard in response to the UN official’s tweet quoting a certain Professor Hart as saying during her visit to Manila that “there is no evidence shabu leads to violence or causes brain damage. #Philippines drug forum.”

To this, Marcos replied in her May 9 column for Bulgar: “Kung wala naman palang scientific evidence na nakababaliw itong shabu, bakit hindi ito ipasubok sa kanya? Pabatakin kaya ang ale na yan ng shabu! Sige, kahit one batak a day na lang for one week o kahit isang buwan at tingnan natin kung walang epek.”

“O baka naman gumagamit na siya nito kaya wala siyang nakikitang diperensya. Wa’ epek sa kanya, ganun?” the governor added.

Callamard was in the country last week to speak at an academic forum on the country’s drug problem.

She has earned President Rodrigo Duterte’s ire for criticizing the administration’s war on drugs and expressing interest to investigate it.

Marcos wondered what evidence of shabu’s destructive effects Callamard needed to see since any doctor would confirm that it negatively affects a person’s brain.

“Kahit siguro sinong doktor ang tanungin mo rito kung anong epekto ng drugs, tiyak na isa lang ang isasagot: Nagkakasapak sa ulo. At yung maraming kaso ng rape, masaker at kung anu-ano pang karumal-dumal na krimen, kadalasan ang may kagagawan ay bumatak ng shabu,” she said.

Facebook Comments
Recommended Articles

Recommended on other sites

Disclaimer:
The comments posted on this site do not necessarily represent or reflect the views of management and owner of POLITICS.com.ph. We reserve the right to exclude comments that we deem to be inconsistent with our editorial standards.

Trending News

Want Politiko alerts on your inbox? Subscribe here.